New study shows MOTOmed movement therapy devices help recovery for sufferers of post-stroke hemiplegia

Enable Me provides several movement therapy devices for patients suffering from neuro-muscular injury or disease, including stroke

TAMPA, Fla., Feb. 25, 2019 (GLOBE NEWSWIRE) — Enable Me, one of the largest U.S. providers of technologically-advanced movement therapy devices that help sufferers of stroke, Parkinson’s and other neuromuscular diseases and injuries, announces new scholarly research concluding that MOTOmed devices improve recovery outcomes for patients with hemiplegia.

The study, published by the Fujian University of Traditional Chinese Medicine and provided to Enable Me by John Hopkins University, focused specifically on patients living with hemiplegia, a permanent post-stroke condition that affects movement on one side of the body.

Nineteen randomized control trials involving a total of 1,099 patients found that the combination of MOTOmed movement therapy and regular rehabilitation improves the mobility and physical activity of hemiplegiac patients.

Hemiplegia (sometimes called hemiparesis) is a condition that affects one side of the body. Often described as right or left hemiplegia, depending on the side affected, it is caused by injury to parts of the brain that control movements of the limbs, trunk, face, etc.

“The results of this latest study confirm earlier research findings showing that motor-assisted, computerized movement therapy devices are vital components in stroke recovery regimens,” commented Mike Laky, CEO of Enable Me. “It’s exciting news that offers even more hope for stroke patients.”

Each year, approximately 795,000 people suffer a stroke. About 600,000 of these are first attacks, and 185,000 are recurrent attacks. Nearly three-quarters of all strokes occur in people over the age of 65. The risk of having a stroke more than doubles each decade after the age of 55.

Enable Me provides a variety of technologically advanced movement therapy devices for patients suffering from neurological conditions, including the MOTOmed muvi, which is the first therapy device of its kind to provide simultaneous therapy of the arms and legs.

Studies show that the application of mobility therapy in the intensive care unit can reduce in-hospital length of stay by an average of 2.7 days, cutting hospital costs and getting patients to their next level of treatment or return home sooner.

Media Contact:

Andrew Bowen, APR